Brief: CohBar Says Temporarily Suspended Early Stage Trial To Address Injection Site Reactions
05/11/2018 14:11
Nov 5 (Reuters) - CohBar Inc CWBR.O :
* COHBAR PROVIDES UPDATE ON CB4211 CLINICAL TRIAL
* COHBAR INC - CB4211 PHASE 1 CLINICAL TRIAL TEMPORARILY
SUSPENDED
TO ADDRESS INJECTION SITE REACTIONS
Source text for Eikon: ID:nGNX6cfHqR
Further company coverage: CWBR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CohBar
See all newsBrief: CohBar, Inc. Q2 EPS USD -1.49
Brief: Morphogenesis And CohBar Announce Positive Results From Phase 1B Trial Of IFX-HU2.0 Personalized Cancer Vaccine, In Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) And Cutaneous Squamous Cell Carcinoma (CSCC)
U.S. STOCKS ON THE MOVE-Galecto, Pinterest, Standard Lithium
CohBar surges on merger agreement with Morphogenesis
U.S. STOCKS ON THE MOVE-Chevron, Broadcom, Williams-Sonoma